Acorda Therapeutics, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Acorda Therapeutics, Inc.
Quantité totale PI 93
Quantité totale incluant filiales 120 (+ 28 pour les filiales)
Rang # Quantité totale PI 14 460
Note d'activité PI 2,5/5.0    40
Rang # Activité PI 18 591
Activité incl filiales 2,3/5.0    44
Symbole boursier
ISIN US00484M6012
Capitalisation 0.821M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

33 11
1 10
24 0
14
 
Dernier brevet 2024 - Sustained release compositions o...
Premier brevet 1993 - Dna encoding glial mitogenic fac...
Dernière marque 2024 - JUST ASK 3 OR MORE IN 24
Première marque 2001 - ACORDA THERAPEUTICS

Filiales

4 subsidiaries with IP (28 patents, 0 trademarks)

2 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Promoting public awareness of the need for education, research, treatment and a cure for diseases...
2023 Invention Sustained release compositions of 4-aminopyridine. The present invention generally relates to su...
Invention Methods of using sustained release aminopyridine compositions. A pharmaceutical composition whic...
Invention Sustained release aminopyridine composition. A pharmaceutical composition which comprises a ther...
2022 Invention Use of neuregulin to treat peripheral nerve injury. The disclosure provides compositions and met...
2021 P/S Pharmaceutical products, namely, pharmaceutical and biological preparations used in the treatment...
P/S Medical devices, namely, drug delivery system in the nature of an oral inhaler that facilitates t...
2020 Invention Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart fa...
Invention Methods for cardiomyocyte survival, proliferation or differentiation by nrg-2. The invention fea...
Invention Method for achieving desired glial growth factor 2 plasma levels. The present invention relates ...
Invention Compositions and methods for treatment during non-acute periods following cns neurological injury...
Invention Methods and compositions for treating cns injury. Disclosed herein are methods and compositions f...
Invention Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis usi...
2019 Invention Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients...
Invention Durable treatment with 4-aminopyridine in patients with demyelination. Disclosed herein are meth...
Invention Compositions and methods including a recombinant human mab that promotes cns remyelination. Anti...
Invention Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart...
Invention Water-soluble acetaminophen analogs. The present invention provides water-soluble acetaminophen p...
Invention Compositions and methods for the treatment of cns injuries. The present invention is directed to...
Invention Carbonate prodrugs and methods of using the same. The present invention provides carbonate prodru...
Invention Methods for detecting cardiac damage. The present invention relates to a method for detecting hea...
2018 Invention Methods for cardiomyocyte survival, proliferation or differentiation by nrg-2. The invention feat...
Invention Use of a neuregulin to treat peripheral nerve injury. Embodiments of the invention are directed ...
Invention Method, apparatus and software for identifying responders in a clinical environment. A process f...
P/S Providing campaigns featuring information to promote public awareness regarding Parkinson's disea...
Invention Hepatoprotectant acetaminophen mutual prodrugs. The present invention provides hepatoprotectant ...
2017 Invention Methods of reducing extravasation of inflammatory cells. A method for modifying access of cells t...
P/S Pharmaceutical products, namely, pharmaceutical and biological preparations for the treatment of ...
P/S Pharmaceutical and biological preparations used in the treatment of diseases, disorders or condit...
2016 P/S Medical devices, namely inhaler and nebulizer delivery devices that facilitate delivery of pharma...
2014 P/S Pharmaceutical products; pharmaceutical and biological preparations used in the treatment of dise...
2013 P/S Pharmaceutical and biological compositions used in the treatment of neurological diseases, disord...
2011 P/S Pharmaceutical preparations for the treatment of function in neurological, neurotrauma, autoimmun...
P/S Pharmaceutical and biological preparations used in the treatment of neurological diseases, disord...
2009 P/S Pharmaceutical and biological preparations, products and formulations used in the treatment of sp...
2004 P/S Pharmaceutical preparations used in the treatment of spinal cord injuries, multiple sclerosis and...
2001 P/S pharmaceuticals.